Salem Investment Counselors’s HOOKIPA Pharma HOOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8
Closed -$66 1139
2023
Q2
$66 Hold
8
﹤0.01% 1131
2023
Q1
$56 Hold
8
﹤0.01% 1103
2022
Q4
$61 Hold
8
﹤0.01% 1076
2022
Q3
$0 Hold
8
﹤0.01% 1070
2022
Q2
$0 Hold
8
﹤0.01% 1090
2022
Q1
$0 Hold
8
﹤0.01% 1043
2021
Q4
$0 Hold
8
﹤0.01% 1085
2021
Q3
$0 Hold
8
﹤0.01% 984
2021
Q2
$1K Buy
+8
New +$1.07K ﹤0.01% 866
2019
Q4
Sell
-90
Closed -$7K 698
2019
Q3
$7K Hold
90
﹤0.01% 555
2019
Q2
$6K Buy
+90
New +$9.55K ﹤0.01% 584

Other funds holding HOOK

Salem Investment Counselors's HOOK Position: Q3 2023 in Review

Salem Investment Counselors sold out of HOOKIPA Pharma (HOOK) in Q3 2023, closing a stake of 8 shares — an estimated $66 sold.

Salem Investment Counselors first reported a position in HOOK in Q2 2019 and held it in 11 quarters. The position peaked at $7K in Q3 2019. 44 funds tracked by Wall St. Rank hold HOOK as of Q3 2023.

  • Salem Investment Counselors reported no remaining HOOKIPA Pharma position as of Q3 2023 after selling out during the quarter.
  • Salem Investment Counselors sold 8 HOOKIPA Pharma shares in Q3 2023, an estimated $66.
  • Salem Investment Counselors first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 11 quarters.
  • Salem Investment Counselors's HOOKIPA Pharma position peaked at $7K in Q3 2019.
  • 44 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2023.

Based on Salem Investment Counselors's 13F filing for Q3 2023, filed 4 Oct 2023.